We are live on ! Find out more
USNA icon

Usana Health Sciences

144 hedge funds and large institutions have $621M invested in Usana Health Sciences in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 42

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

1% less funds holding

Funds holding: 145144 (-1)

0.91% less ownership

Funds ownership: 45.46%44.55% (-0.91%)

2% less call options, than puts

Call options by funds: $4.68M | Put options by funds: $4.75M

13% less capital invested

Capital invested by funds: $714M → $621M (-$93.2M)

Holders
144
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
3.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
52
Reduced
42
Closed
23
Calls
$4.68M
Puts
$4.75M
Net Calls
-$76K
Net Calls Change
-$712K

USNA Hedge Fund Activity: Q3 2017 in Review

144 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2017, worth a combined $621M — down 13% from $714M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 23 closed out — a net gain of 1 holder — while 52 added to existing stakes and 42 trimmed.

The largest buyer was Norges Bank, adding an estimated $10.1M. The largest seller was Two Sigma Investments, cutting an estimated $7.68M.

  • 144 institutional investors held Usana Health Sciences (USNA) as of Q3 2017, down from 145 in Q2 2017.
  • Funds reported $621M of Usana Health Sciences stock for Q3 2017, down 13% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q3 2017 and 23 closed out, a net change of +1 holder.
  • The largest Usana Health Sciences buyer in Q3 2017 was Norges Bank, an estimated $10.1M added.
  • The largest Usana Health Sciences seller in Q3 2017 was Two Sigma Investments, an estimated $7.68M sold.

Based on aggregated 13F filings for Q3 2017.